The real 2026 Ozempic price list
Ozempic’s Novo Nordisk 2026 list price is $997.58 per month (pen, any dose strength). That number is essentially the same across chain pharmacies once manufacturer fees and pharmacy margins are applied — a CVS, Walgreens, Costco, Walmart, or Kroger will all land within $20–$50 of list. Independent pharmacies and compounding operations that also stock branded pens sometimes list $1,050–$1,150 to cover lower purchasing leverage.
The list price is almost never what you actually pay. The five paths that matter:
- Commercial copay with savings card: $25/month. If your employer or marketplace plan covers Ozempic with a copay, the Novo Nordisk Ozempic savings card brings a 1-month supply to as little as $25 (maximum annual benefit applies). This is the cheapest legal branded path in 2026.
- Commercial copay without savings card: $25–$250/month. Specialty tier copays vary widely. A plan that lists Ozempic on Tier 3 specialty might charge $150/month; an HDHP will charge full negotiated price (typically $600–$850) until you hit your deductible.
- Cash pay at pharmacy: $850–$1,050/month.GoodRx and SingleCare coupons typically land around $850–$950 in 2026. Costco and Sam’s Club sometimes price $20–$40 under list without a coupon for members. This is the most expensive legal path for ongoing therapy.
- Compounded semaglutide: $199–$349/month when clinically justified. Post-shortage (late 2024 onward), compounded semaglutide is restricted to documented individual medical necessity under 503A. The mass-market $200/month telehealth model has largely disappeared.
- Telehealth bundle (branded): $999–$1,200/month all-in. Covers the visit, pen, and shipping. Rarely cheaper than cash pay plus a local PCP visit unless you have no provider access.
Ozempic is a diabetes drug — what changes if you don’t have T2D
Ozempic’s FDA label covers Type 2 diabetes and, as of the 2024 update, reduction of major adverse cardiovascular events (MACE) in adults with T2D and established cardiovascular disease. It is not FDA-approved for weight loss. Most commercial formularies will cover Ozempic only when a valid T2D ICD-10 code (E11.xx) is on the request. Without that, your prior authorization will almost always deny — and your pharmacist cannot dispense the pen without plan approval in a Tier 3 specialty slot.
If you are pursuing GLP-1 therapy primarily for weight management without T2D, Wegovy, Zepbound, and compounded tirzepatide (with the same clinical-necessity caveat) are the on-label options. Chasing cash-pay Ozempic off-label is almost never the right financial move in 2026 — especially when LillyDirect self-pay Zepbound vials are $499/month.
What the Novo Nordisk Ozempic savings card actually covers
The 2026 Ozempic savings card terms (commercially insured, eligible plan):
- Covered copay as low as $25 for a 1-month supply.
- Maximum benefit of $150 off per 1-month supply (so a $200 copay becomes $50).
- Annual benefit cap of $1,800 (resets each calendar year).
- Not valid with Medicare Part D, Medicaid, TRICARE, VA, or any federal/state program.
- Not stackable with any other discount, coupon, or patient assistance program.
If your plan doesn’t cover Ozempic, the card drops to a modest cash-pay discount (~$150 off list) that is rarely competitive with GoodRx.
Annualize everything — monthly numbers lie
A “$199/month” compounded plan costs $2,388/year. A “$25 copay” with a savings card that caps at $1,800 of benefit may only cost $25 for the first 7–9 months, then jump to full copay for the rest of the year. Always run the 12-month total before picking a path, and re-run it every January when savings-card benefit caps reset. The calculator above handles this automatically — just set the months field to 12.
Cross-check these tools before you commit
Ozempic cost is one decision in a longer chain. Run the insurance coverage checker to estimate whether your plan will cover it at all. If you’re facing a denial, the prior-auth guide and appeal checklist walks through diagnosis codes and prior-diet documentation. If you don’t have T2D, compare Ozempic directly against Wegovy, Zepbound, and the LillyDirect vial option. And if you’re weighing branded vs compounded tradeoffs, the generic vs brand comparison spells out the cost-vs-risk math.